Research News – Monday, April 15,2024
Published: Monday, April 15, 2024
Notices and Reminders
NIH is implementing multiple changes that will impact the preparation and peer review of most grant applications submitted to NIH for due dates on or after January 25, 2025.
OUHSC IRB Listserv – Subscribe Today!
The OUHSC IRB is excited to announce that we have created a listserv to share important IRB updates and announcements with researchers and research staff.
Subrecipient Intent Documents
When an outside entity is completing programmatic work on an OUHSC grant application, a subrecipient intent form is required along with a scope of work, budget, budget justification, and other proposal documents as necessary. This intent to enter into a collaboration with OUHSC must be signed by an Authorized Official of the outside entity. It is OUHSC’s responsibility as the prime institution to have documentation that the outside entity has officially approved the proposed collaboration before we propose the collaboration to the sponsor. Some sponsors (such as NIH) require this documentation as part of the application. However, even if the sponsor does not have a requirement for these documents to be submitted with the application, it is an OUHSC requirement to have these documents as part of the review process. Subrecipient intent documents must be received by the three-day ORA review deadline or a waiver request form must be submitted to the Associate Vice President for Research Administration via email.
LIBRARY RESOURCES: Please find a list of resources the Robert M. Bird Library has to offer attached to this email. Web:
http://library.ouhsc.edu/ and Twitter: @ouhsclibrary
Workshops and Seminars
Introducing GenoBioTX/Shanghai Model Organisms Center: Your Trusted Partner in Life Sciences and Biomedical Research presented by Adrei Golovko, PhD, MBA on April 16, 2024 at 12:00 PM in the Bird Library Auditorium. Flyer with additional information is attached.
2024 Web of Life Conference
Date: 4/25/2024 - 4/26/2024
Location: Nicholson Auditorium, 1000 NE 13th St, Oklahoma City, OK 73104
Description: Major diseases such as cancer, cardiovascular disorders, diabetes, obesity, aging, and neurodegeneration are often studied and treated in isolation. Yet, each of them may be related, causally or otherwise, to one another. Therefore, facilitating crosstalk among these is expected to foster multidisciplinary collaboration and drive innovative and effective solutions.
The two-day Web of Life Conference will be hosted for the first time by the University of Oklahoma Health Sciences Center in April 2024. To realize the full potential of team science, we are bringing stalwarts from disparate yet connected fields such as cancer, diabetes, ageing bioengineering, and neurodegeneration to unite them under the common theme - “Web of Life: Connecting the Dots.” This collaboration will significantly impact and improve the way we engage communities, treat patients, foster collaboration, and facilitate groundbreaking discoveries.
OUHSC Funding Opportunities
Oklahoma Biotech Startup Programs Concept Program
OKBioStart Program is a grant-funded, multi-institutional program for innovators, founders, and the life science community in the greater Oklahoma City ten-county region that accelerates the translation of innovative concepts into commercially viable life sciences (Biotech, MedTech, or Virtual Health) technologies. See program announcement attached for specific deadline dates associated with each program.
Center for Indigenous Resilience, Culture, and Maternal Health Equity (CIRCLE) Request for Letters of Intent: Pilot Projects
Description: The CIRCLE Pilot Projects program seeks to support novel clinical and translational ideas that impact the understanding and solution of Indigenous maternal mortality and morbidity (MMM) or maternal health disparities. This program will support proposals designed to generate preliminary data that enhances the competitiveness of the investigators for extramural funding while furthering our understanding of MMM to improve maternal health outcomes for Indigenous mothers in Oklahoma and the Southern Plains. CIRCLE plans to fund up to 4 pilot projects in 2024 for up to $25,000 each.
Deadline for Letters of Intent: May 1, 2024
Link to the Full Announcement: Please see attached (CIRCLE pilot project application 2024)
Office of Technology Commercialization presents the following opportunity for Office of Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click
here for more information, or email
otc@ou.edu or
gina-mcmillen@ouhsc.edu).
LifeArc, a non-profit medical research organization, is seeking innovative proposals to boost drug repurposing in motor neuron disease. Approaches of interest include preclinical stage research with a repurposed drug or drug combination. Submission of an Expression of Interest form is required as part of the application process; more information can be found at the
LifeArc – Drug Repurposing in MND.
Deadline May 10th.
(NOT-NS-24-068)
(NOT-HD-24-018)
NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted). The letters of intent will be reviewed and a single application will be chosen for submission from the University.
NIH Funding Opportunities